Skip to main navigation Skip to search Skip to main content

Treatment of anemia with darbepoetin alfa in systolic heart failure

Karl Swedberg, James B Young, Inder S Anand, Sunfa Cheng, Akshay S Desai, Rafael Diaz, Aldo P Maggioni, John J V McMurray, Christopher O'Connor, Marc A Pfeffer, Scott D Solomon, Hong Yan Sun, Michal Tendera, Dirk J van Veldhuisen, RED-HF Committees, Jens Erik Rokkedal Nielsen

508 Citations (Scopus)

Abstract

Patients with systolic heart failure and anemia have worse symptoms, functional capacity, and outcomes than those without anemia. We evaluated the effects of darbepoetin alfa on clinical outcomes in patients with systolic heart failure and anemia.
Original languageEnglish
JournalThe New England journal of medicine
Volume368
Issue number13
Pages (from-to)1210-9
Number of pages10
ISSN0028-4793
DOIs
Publication statusPublished - 28 Mar 2013

Keywords

  • Aged
  • Anemia
  • Double-Blind Method
  • Erythropoietin
  • Female
  • Heart Failure, Systolic
  • Hematinics
  • Hemoglobins
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Shock, Septic
  • Stroke
  • Thromboembolism
  • Treatment Failure

Fingerprint

Dive into the research topics of 'Treatment of anemia with darbepoetin alfa in systolic heart failure'. Together they form a unique fingerprint.

Cite this